CD38 is a potential treatment target in lymphoma patients concurrently infected with human immunodeficiency virus

Trine Engelbrecht Hybel; Maja Ølholm Vase; Kristina Lystlund Lauridsen; Marie Beck Enemark; Michael Boe Møller; Court Pedersen; Gitte Pedersen; Stephen Hamilton-Dutoit; Niels Obel; Carsten Schade Larsen; Francesco d’Amore; Maja Ludvigsen

doi:10.1080/10428194.2021.2023741

CD38 is a potential treatment target in lymphoma patients concurrently infected with human immunodeficiency virus

Trine Engelbrecht Hybel, Maja Ølholm Vase, Kristina Lystlund Lauridsen, Marie Beck Enemark, Michael Boe Møller, Court Pedersen, Gitte Pedersen, Stephen Hamilton-Dutoit, Niels Obel, Carsten Schade Larsen, Francesco d’Amore, Maja Ludvigsen^*

^*Corresponding author af dette arbejde

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avis › Kommentar/debat/letter to the editor › Forskning › peer review

3 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	Leukemia & Lymphoma
Vol/bind	63
Nummer	6
Sider (fra-til)	1479-1483
Antal sider	5
ISSN	1042-8194
DOI	https://doi.org/10.1080/10428194.2021.2023741
Status	Udgivet - maj 2022

Adgang til dokumentet

10.1080/10428194.2021.2023741

Andre filer og links

Link to publication in Scopus

Citationsformater

Hybel, T. E., Vase, M. Ø., Lauridsen, K. L., Enemark, M. B., Møller, M. B., Pedersen, C., Pedersen, G., Hamilton-Dutoit, S., Obel, N., Schade Larsen, C., d’Amore, F., & Ludvigsen, M. (2022). CD38 is a potential treatment target in lymphoma patients concurrently infected with human immunodeficiency virus. Leukemia & Lymphoma, 63(6), 1479-1483. https://doi.org/10.1080/10428194.2021.2023741

@article{123d636b985f4cefbbbb0458304608a2,

title = "CD38 is a potential treatment target in lymphoma patients concurrently infected with human immunodeficiency virus",

author = "Hybel, {Trine Engelbrecht} and Vase, {Maja {\O}lholm} and Lauridsen, {Kristina Lystlund} and Enemark, {Marie Beck} and M{\o}ller, {Michael Boe} and Court Pedersen and Gitte Pedersen and Stephen Hamilton-Dutoit and Niels Obel and {Schade Larsen}, Carsten and Francesco d{\textquoteright}Amore and Maja Ludvigsen",

note = "Funding Information: This work was made possible through Aarhus University, the Karen Elise Jensen Foundation, the Eva and Henry Fraenkel Foundation, the Einar Willumsen{\textquoteright}s Memorial Foundation, and the Danish Lymphoma Group.",

year = "2022",

month = may,

doi = "10.1080/10428194.2021.2023741",

language = "English",

volume = "63",

pages = "1479--1483",

journal = "Leukemia & Lymphoma",

issn = "1042-8194",

publisher = "Informa Healthcare",

number = "6",

}

Hybel, TE, Vase, MØ, Lauridsen, KL , Enemark, MB, Møller, MB, Pedersen, C, Pedersen, G, Hamilton-Dutoit, S, Obel, N, Schade Larsen, C , d’Amore, F & Ludvigsen, M 2022, 'CD38 is a potential treatment target in lymphoma patients concurrently infected with human immunodeficiency virus', Leukemia & Lymphoma, bind 63, nr. 6, s. 1479-1483. https://doi.org/10.1080/10428194.2021.2023741

CD38 is a potential treatment target in lymphoma patients concurrently infected with human immunodeficiency virus. / Hybel, Trine Engelbrecht; Vase, Maja Ølholm; Lauridsen, Kristina Lystlund et al.
I: Leukemia & Lymphoma, Bind 63, Nr. 6, 05.2022, s. 1479-1483.

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avis › Kommentar/debat/letter to the editor › Forskning › peer review

TY - JOUR

T1 - CD38 is a potential treatment target in lymphoma patients concurrently infected with human immunodeficiency virus

AU - Hybel, Trine Engelbrecht

AU - Vase, Maja Ølholm

AU - Lauridsen, Kristina Lystlund

AU - Enemark, Marie Beck

AU - Møller, Michael Boe

AU - Pedersen, Court

AU - Pedersen, Gitte

AU - Hamilton-Dutoit, Stephen

AU - Obel, Niels

AU - Schade Larsen, Carsten

AU - d’Amore, Francesco

AU - Ludvigsen, Maja

N1 - Funding Information: This work was made possible through Aarhus University, the Karen Elise Jensen Foundation, the Eva and Henry Fraenkel Foundation, the Einar Willumsen’s Memorial Foundation, and the Danish Lymphoma Group.

PY - 2022/5

Y1 - 2022/5

UR - http://www.scopus.com/inward/record.url?scp=85122825283&partnerID=8YFLogxK

U2 - 10.1080/10428194.2021.2023741

DO - 10.1080/10428194.2021.2023741

M3 - Comment/debate/letter to the editor

C2 - 35019824

AN - SCOPUS:85122825283

SN - 1042-8194

VL - 63

SP - 1479

EP - 1483

JO - Leukemia & Lymphoma

JF - Leukemia & Lymphoma

IS - 6

ER -